Market Cap: $7.09M
CL
CollPlant Biotechnologies Ltd.
CLGN
NASDAQ (NASDAQ Global Market)USD
Market Cap: $7.09M
CollPlant Biotechnologies Faces Nasdaq Compliance Challenge CollPlant Biotechnologies, a prominent player in the regenerative and aesthetic medicine sector, currently navigates a critical compliance c…
CollPlant Biotechnologies: Pioneering Developments in Regenerative Medicine CollPlant Biotechnologies is at the forefront of innovation in the field of regenerative medicine, focusing on the developme…
CollPlant Biotechnologies Prepares for Critical Earnings Announcement CollPlant Biotechnologies is on the cusp of announcing its quarterly earnings on November 26, 2025, a milestone that holds signifi…
CollPlant Biotechnologies Prepares for Earnings Release Amid Strategic Growth Focus As CollPlant Biotechnologies approaches its quarterly earnings announcement scheduled for November 26, 2025, the reg…
CollPlant Biotechnologies Expands North American Operations with New Logistics Center CollPlant Biotechnologies, a leader in regenerative and aesthetic medicine, announces its strategic expansion into…
CollPlant Biotechnologies Expands North American Presence with New Logistics Partnership CollPlant Biotechnologies, a pioneer in regenerative and aesthetic medicine, announces a strategic expansion in…
Advancements in Tissue Engineering: CollPlant's Breakthrough Bioink Technology CollPlant Biotechnologies, based in Rehovot, Israel, is making significant strides in the field of tissue engineering wit…
CollPlant's Bioink Breakthrough: A New Era in Tissue Engineering CollPlant Biotechnologies, based in Rehovot, Israel, marks a significant advancement in the field of tissue engineering with its new rh…
CollPlant Advances Ethical Research with Revolutionary Bioprinted Skin Model CollPlant Biotechnologies, a leader in regenerative and aesthetic medicine, is at the forefront of innovation with its rece…
CollPlant Biotechnologies Advances with Innovative Dermal Filler CollPlant Biotechnologies, a pioneering company based in Rehovot, Israel, is on the cusp of entering clinical trials for its groundbrea…
CollPlant Biotechnologies Nears Clinical Trials for Innovative Dermal Filler CollPlant Biotechnologies, an Israeli firm based in Rehovot, is on the cusp of advancing its groundbreaking photocurable de…
CollPlant Biotechnologies Expands Distribution of Vergenix™ STR in Europe CollPlant Biotechnologies (NASDAQ: CLGN), a frontrunner in regenerative and aesthetic medicine, announces a pivotal expansion…
CollPlant Expands European Footprint with Vergenix™ STR in Poland CollPlant Biotechnologies, a leader in regenerative and aesthetic medicine, is making significant strides in its European distribution…
CollPlant Biotechnologies Showcases Innovative Solutions in Regenerative Medicine CollPlant Biotechnologies, a pioneer in regenerative and aesthetic medicine, gears up for its participation in the upc…
CollPlant Biotechnologies Showcases Innovations in Regenerative Medicine at Upcoming Conference CollPlant Biotechnologies, a trailblazer in regenerative and aesthetic medicine, prepares to participate…
CollPlant Biotechnologies Poised for Key Earnings Report Amid Growth in Regenerative Medicine CollPlant Biotechnologies is gearing up for its quarterly earnings report set to be released on August 20,…
CollPlant Biotechnologies Poised for Pivotal Earnings Report CollPlant Biotechnologies, a leader in the regenerative medicine sector, prepares to unveil its quarterly earnings report on August 20, 202…
Innovative Advancements in CollPlant's Bioprinted Tissues CollPlant Biotechnologies is making significant strides in the field of regenerative medicine with its cutting-edge bioprinting technology, pa…